These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 3196727)

  • 1. Monoclonal DLR1a/104G antibody recognizing peroxidized lipoproteins in atherosclerotic lesions.
    Mowri H; Ohkuma S; Takano T
    Biochim Biophys Acta; 1988 Nov; 963(2):208-14. PubMed ID: 3196727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxidized lipoproteins recognized by a new monoclonal antibody (DLR1a/104G) in atherosclerotic lesions.
    Takano T; Mowri H
    Ann N Y Acad Sci; 1990; 598():136-42. PubMed ID: 2248433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxidized lipids isolated by HPLC from atherosclerotic aorta.
    Mowri H; Chinen K; Ohkuma S; Takano T
    Biochem Int; 1986 Feb; 12(2):347-52. PubMed ID: 3964289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct evidence for a protein recognized by a monoclonal antibody against oxidatively modified LDL in atherosclerotic lesions from a Watanabe heritable hyperlipidemic rabbit.
    Boyd HC; Gown AM; Wolfbauer G; Chait A
    Am J Pathol; 1989 Nov; 135(5):815-25. PubMed ID: 2683796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of oxidized low-density lipoprotein and large molecular size low-density lipoproteins in atherosclerosis.
    Kanazawa T; Osanai T; Uemura T; Onodera K; Oike Y
    Pathobiology; 1993; 61(3-4):200-10. PubMed ID: 8216842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Demonstration of the presence of lipid peroxide-modified proteins in human atherosclerotic lesions using a novel lipid peroxide-modified anti-peptide antibody.
    Kim JG; Taylor WR; Parthasarathy S
    Atherosclerosis; 1999 Apr; 143(2):335-40. PubMed ID: 10217362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibody EMR1a/212D recognizing site of deposition of extracellular lipid in atherosclerosis: purification and characterization of the antigen.
    Nakagami K; Shimazaki O; Sato R; Komine Y; Ohkuma S; Takano T
    Am J Pathol; 1989 Jul; 135(1):93-100. PubMed ID: 2476036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage-derived foam cells freshly isolated from rabbit atherosclerotic lesions degrade modified lipoproteins, promote oxidation of low-density lipoproteins, and contain oxidation-specific lipid-protein adducts.
    Rosenfeld ME; Khoo JC; Miller E; Parthasarathy S; Palinski W; Witztum JL
    J Clin Invest; 1991 Jan; 87(1):90-9. PubMed ID: 1985115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low density lipoprotein undergoes oxidative modification in vivo.
    Palinski W; Rosenfeld ME; Ylä-Herttuala S; Gurtner GC; Socher SS; Butler SW; Parthasarathy S; Carew TE; Steinberg D; Witztum JL
    Proc Natl Acad Sci U S A; 1989 Feb; 86(4):1372-6. PubMed ID: 2465552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production and characterization of monoclonal antibodies to oxidized LDL.
    Choi K; Lee HS; Chung HK
    Exp Mol Med; 1998 Mar; 30(1):41-5. PubMed ID: 9873821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of electronegative low density lipoprotein (LDL-) in plasma and atherosclerotic lesions by monoclonal antibody-based immunoassays.
    Damasceno NR; Sevanian A; Apolinário E; Oliveira JM; Fernandes I; Abdalla DS
    Clin Biochem; 2006 Jan; 39(1):28-38. PubMed ID: 16310760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The production and use of monoclonal antibodies to measure apolipoprotein B by a competitive enzyme-linked immunoassay.
    Waterson M; Samuel L; Miller E; Norman M
    Ann Clin Biochem; 1987 May; 24 ( Pt 3)():301-8. PubMed ID: 3111342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Appearance of cross linked proteins in human atheroma and rat pre-fibrotic liver detected by a new monoclonal antibody.
    Itabe H; Jimi S; Kamimura S; Suzuki K; Uesugi N; Imanaka T; Shijo H; Takano T
    Biochim Biophys Acta; 1998 Feb; 1406(1):28-39. PubMed ID: 9545523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemical characterization of peroxidized low-density lipoprotein in plasma and aortic atheroma.
    Kanazawa T; Osanai T; Uemura T; Onodera K; Metoki H
    Pathobiology; 1996; 64(1):18-26. PubMed ID: 8856791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma.
    Palinski W; Hörkkö S; Miller E; Steinbrecher UP; Powell HC; Curtiss LK; Witztum JL
    J Clin Invest; 1996 Aug; 98(3):800-14. PubMed ID: 8698873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. XeCl laser-induced fluorescence of atherosclerotic arteries. Spectral similarities between lipid-rich lesions and peroxidized lipoproteins.
    Oraevsky AA; Jacques SL; Pettit GH; Sauerbrey RA; Tittel FK; Nguy JH; Henry PD
    Circ Res; 1993 Jan; 72(1):84-90. PubMed ID: 8417849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Esterified lipid hydroperoxide-derived modification of protein: formation of a carboxyalkylamide-type lysine adduct in human atherosclerotic lesions.
    Kawai Y; Fujii H; Kato Y; Kodama M; Naito M; Uchida K; Osawa T
    Biochem Biophys Res Commun; 2004 Jan; 313(2):271-6. PubMed ID: 14684156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malondialdehyde-modified low density lipoproteins in patients with atherosclerotic disease.
    Holvoet P; Perez G; Zhao Z; Brouwers E; Bernar H; Collen D
    J Clin Invest; 1995 Jun; 95(6):2611-9. PubMed ID: 7769103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soy protein isolate reduces the oxidizability of LDL and the generation of oxidized LDL autoantibodies in rabbits with diet-induced atherosclerosis.
    Damasceno NR; Goto H; Rodrigues FM; Dias CT; Okawabata FS; Abdalla DS; Gidlund M
    J Nutr; 2000 Nov; 130(11):2641-7. PubMed ID: 11053500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of oxidized phospholipid-protein adducts using anti-15-hydroperoxyeicosatetraenoic acid-modified protein antibody: contribution of esterified fatty acid-protein adduct to oxidative modification of LDL.
    Kato Y; Osawa T
    Arch Biochem Biophys; 1998 Mar; 351(1):106-14. PubMed ID: 9500842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.